Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Ligand Pharmaceuticals Ownership Summary

Ligand Pharmaceuticals is owned by 98.07% institutional investors, 1.89% insiders, and 0.05% retail investors. Blackrock is the largest institutional shareholder, holding 16.19% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.38% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ligand Pharmaceuticals	98.07%	1.89%	0.05%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	2.87M	16.19%	$241.95M
Vanguard group	1.93M	10.87%	$162.36M
Janus henderson group	1.01M	5.69%	$84.99M
Macquarie group	966.55K	5.45%	$81.44M
Dimensional fund advisors lp	708.62K	4.00%	$59.71M
State street	688.77K	3.88%	$58.04M
Stephens investment management group	652.00K	3.68%	$54.94M
Congress asset management co /ma	586.62K	3.31%	$49.43M
Chicago capital	514.95K	2.90%	$43.39M
Villere st denis j	483.91K	2.73%	$40.77M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ashford capital management	322.21K	3.67%	$27.15M
Villere st denis j	483.91K	3.45%	$40.77M
Cardinal capital management llc /ct	133.67K	3.08%	$11.26M
Acuitas investments	54.68K	2.47%	$4.61M
Rice hall james & associates	292.48K	1.48%	$24.64M
Private capital management	134.50K	1.32%	$11.33M
Chicago capital	514.95K	1.29%	$43.39M
Essex investment management	70.78K	1.12%	$5.96M
Stephens investment management group	652.00K	0.77%	$54.94M
Jackson creek investment advisors	13.60K	0.42%	$1.15M

Top Buyers

Holder	Shares	% Assets	Change
Congress asset management co /ma	586.62K	0.35%	586.62K
Chicago capital	514.95K	1.29%	285.35K
Loomis sayles & co l p	258.34K	0.03%	258.34K
F/m investments	134.71K	0.41%	134.71K
Private capital management	134.50K	1.32%	134.50K

Top Sellers

Holder	Shares	% Assets	Change
Cardinal capital management llc /ct	133.67K	3.08%	-425.56K
Knott david m jr	-	-	-85.00K
Man group	-	-	-68.66K
Macquarie group	966.55K	0.09%	-66.63K
Morgan stanley	194.34K	0.00%	-57.56K

New Positions

Holder	Shares	% Assets	Change	Value
Congress asset management co /ma	586.62K	0.35%	586.62K	$49.43M
Loomis sayles & co l p	258.34K	0.03%	258.34K	$21.77M
F/m investments	134.71K	0.41%	134.71K	$11.35M
Private capital management	134.50K	1.32%	134.50K	$11.33M
Congress wealth management llc / de /	88.25K	0.12%	88.25K	$7.44M

Sold Out

Holder	Change
Tidemark	-4.00
Avion wealth	-9.00
Financial synergies wealth advisors	-13.00
Sachetta	-21.00
Stephens consulting	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	245	4.26%	18,062,996	4.71%	98	1.04%	135	9.76%	53	-26.39%
Jun 30, 2024	232	2.65%	17,221,379	4.99%	97	1.08%	122	23.23%	70	-
Mar 31, 2024	226	4.63%	16,402,720	1.60%	94	1.10%	99	-6.60%	70	-4.11%
Dec 31, 2023	216	9.09%	16,144,849	3.07%	92	1.13%	106	26.19%	73	-6.41%
Sep 30, 2023	198	-3.41%	15,664,612	0.61%	90	1.09%	84	-17.65%	78	14.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	1.17M	6.38%	1.13K
Delaware Small Cap Core I	655.86K	3.59%	-57.44K
Janus Henderson US SMID Cap Growth	626.08K	3.43%	-
Janus Henderson Triton D	626.08K	3.43%	-
Vanguard Total Stock Mkt Idx Inv	530.75K	2.83%	892.00
iShares Russell 2000 ETF	438.64K	2.40%	-980.00
Stephens SMID Select Growth	425.39K	2.33%	1.23K
Vanguard Small Cap Index	435.91K	2.32%	850.00
Congress Asset Mgt Small Cap Growth	350.00K	1.92%	350.00K
Congress Small Cap Growth Institutional	350.00K	1.87%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 27, 2024	LAMATTINA JOHN L	-	Sell	$297.50K
Sep 23, 2024	Reardon Andrew	CLO & Secretary	Sell	$199.20K
Sep 20, 2024	Espinoza Octavio	Chief Financial Officer	Sell	$20.80K
Sep 20, 2024	Espinoza Octavio	Chief Financial Officer	Sell	$83.16K
Sep 20, 2024	Espinoza Octavio	Chief Financial Officer	Sell	$28.56K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	1	15
2024 Q2	-	9
2024 Q1	-	2
2023 Q4	-	-

LGND Ownership FAQ

Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 98.07%, followed by 1.89% insiders and 0.04% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Ligand Pharmaceuticals exceeds.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Blackrock (2.87M shares, 16.19%), Vanguard group (1.93M shares, 10.87%), and Janus henderson group (1.01M shares, 5.69%). Together, they hold 32.75% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.67% of its assets in 322.21K Ligand Pharmaceuticals shares, valued at 27.15M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 6.38% of its total shares outstanding invested in 1.17M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools